The Centers for Disease Control and Prevention abruptly ordered its staff to cease all collaboration with the World Health ...

Moderna has been awarded approximately $590 million from the federal government to help speed up the development of an ...

Pfizer-BioNTech and Novavax, the other licensed manufacturers of coronavirus vaccines in the United States, are also developing combined vaccines, but Moderna is further along in releasing data.

Moderna received a $590 million award from the U.S. government to speed development of a vaccine that could be used to fight bird flu.

Moderna conducts phase 3 trial for norovirus vaccine as cases rise in the U.S., with results expected in late 2025 or early 2026.

Moderna and Pfizer are in talks with the federal ... “We continue to have active conversations with both manufacturers, and the negotiations are ongoing,” O’Connell said.

Shares of Moderna Inc. fell sharply on Monday after the biotech firm projected a steep decline in 2025 revenues, falling below Wall Street expectations. The company, known for its COVID-19 vaccine ...

Moderna is set to receive $590m in funding from the HHS to expedite the development of mRNA-based pandemic influenza vaccines ...

Fifteen European countries have secured an agreement with the American COVID-19 vaccine manufacturer Moderna through the European Commission f ...

Scroll through the chart below to see which side effects are common based on your age group, which manufacturer's vaccine ... For Pfizer's and Moderna's two-shot vaccines, the second shot ...

Biopharma executives were busy Monday, striking high-value deals and providing updates on cancer, obesity and vaccine ...

Brooklyn Investment Group reduced its holdings in Moderna, Inc. (NASDAQ:MRNA – Free Report) by 34.8% during the 4th quarter, ...